The Life Science Alliance and the MOLIT institute of personalized medicine are excited to invite you to our first joint-symposium in Heilbronn. The symposium brings together researchers from across the globe to address the promises and challenges of artificial intelligence in healthcare. We are at the forefront of a revolution in healthcare. While new technologies enable us to generate a wealth of data, the next challenge lies in harnessing this information to uncover clinically relevant findings. Over two days we will highlight the latest insights and applications of AI across the whole healthcare system, from bench to bedside in our global community.
The conference assembles leading basic and clinical researchers to share and discuss the latest on:
- Using big data to make intelligent predictions about disease, responses to treatment, or diagnoses,
- The translation of AI technologies to the clinic and its implications for patients,
- Ethical and societal issues to consider when introducing AI technology to the public,
- The rise of smart systems and technologies that change the way we manage health, and the broader approach to healthcare.
This conference offers a rich opportunity to hear from, and interact with, leaders in the effort to establish AI in healthcare systems all over the world.
Dual format: COVID-19 Update and guidance
Given the current restrictions on international travel, we are running this event with a dual in-person and virtual format. For those of our participants and speakers who are unable to travel, or would prefer to participate from the satefy and comfort of their home or office then we invite you to join virtually.
The in-person even is being organized in accordance with the local policies on COVID-19. Social distancing at the venue will be repected with 1.5m spacing in the auditorium and networking in large, open spaces (where possible) with facial coverings. We assure you that we are working to create a safe environment for those of you who will join us in Heilbronn!
Director Life Science Alliance & Senior Scientist, EMBL Heidelberg
Co-founder MOLIT institute for personalized medicine, Heilbronn
Co-founder MOLIT institute for personalized medicine, Heilbronn
Note for Program:
This is a preliminary program for the in-person event. We are in the process of modifying the program to allow for virtual participation across multiple time zones and this will be updated shortly.
Registration fees include admission, conference materials, meals and coffee breaks. Participants are expected to book and pay their own accommodation and travel expenses.
In order to comply with local COVID-19 measures, only 80 in-person registrations are available to accomodate for social distancing measures in the venue. We have hygiene plans in place to ensure that our participants are as safe as possible. Participants will be seated 1.5m apart in the auditorium and networking can either be conducted virtually, or socially distanced with facial coverings.
You should act upon the latest information and advice from the government of the country to which you are travelling. If you are travelling to Heilbronn, you can find information in English at the German Federal Ministry of Health.
In Person Fees:
- Students (with valid ID) €50
- Academia €200
- Industry €400
- Registration will be on a first-come first-served basis. Your place can only be confirmed after payment of the registration fee.
In parallel to the in-person event, we are also planning for a virtual event in case travel restrictions prevent our speakers and participants from joining us in Heilbronn. In this case, any in-person fees paid in full will be refunded, and you will have the option to join the virtual symposium at a reduced rate. We would however encourage you to register for the in-person event to secure your place and help with our planning. The fees for attending the virtual conference are as follows:
- Students (with valid ID) €0
- Academia €50
- Industry €100
Check out our financial assistance tab for fee waivers! Submit an abstract and you could attend for free to share your work on an international stage.
We will only be considering abstracts from registered participants via Converia (our online system). Please therefore ensure that you have registered before submitting your abstract.
Once you have registered, you are welcome to submit your abstract using the "submit a paper" function in Converia. While submitting your abstract you'll be able to choose if you would like to apply for a short talk or a poster presentation only.
Please choose the "submit a paper" option in Converia. You have the option of uploading your abstract as a PDF or as free text. The abstract should not exceed 300 words. The title and author information is added via the system and is not required in the text of the abstract. Any abstracts which are over the word limit, will not be considered.
The abstracts that you submit will be evaluated by the scientific organisers of the meeting and will be selected for either a short talk or poster presentation. Applicants not selected for a talk will still have the opportunity to present a poster during the poster sessions of the meeting. The selection normally takes place around 2 weeks after the abstract submission closes.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at bms.com/de or follow us on Twitter.
Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol-Myers Squibb company and Juno Therapeutics, a Bristol-Myers Squibb company.
In case of any questions, feel free to email the organising team.
Tanja and Katie are happy to help and look forward to welcoming you in Heilbronn.
MOLIT institute of Personalized Medicine, Heilbronn
Life Science Alliance,
The Life Science Alliance is a joint research initiative dedicated to the advancement of biomedical research. By bringing together leading researchers from the European Molecular Biology Laboratory (EMBL) and Stanford University, we are cultivating new ideas, sharing best practices, and facilitating access to technology and resources. We enable transatlantic cooperation with programs for joint research fellows, exchanges and outreach. We are excited to team up with our colleagues at MOLIT and meet more of the local resarch community in Heilbronn.
The MOLIT Institute for Personalized Medicine joins the Life Science Alliance as Co-Organizer. MOLIT is a non-profit research institute for personalized medicine located in Heilbronn, Germany. Its focus is the development of customized therapies for cancer diseases and their translation into general medical care. It is adopting an integrated approach of medicine and IT by joining and mathematically modelling complex data of different molecular analytical methods as well as clinical and patient reported outcome.
This conference is jointly brought to you by: